Acuta Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,000
Closed -$655K 46
2023
Q1
$655K Hold
6,000
0.48% 26
2022
Q4
$683K Buy
6,000
+2,000
+50% +$228K 0.42% 30
2022
Q3
$248K Sell
4,000
-31,888
-89% -$1.98M 0.11% 36
2022
Q2
$2.86M Buy
35,888
+2,688
+8% +$214K 1.59% 20
2022
Q1
$3.49M Buy
+33,200
New +$3.49M 1.63% 24
2015
Q1
Sell
-167,491
Closed -$2.16M 72
2014
Q4
$2.16M Buy
+167,491
New +$2.16M 1.46% 16